Announcements Trials
Browse Landscape

Phase

Phase NA 5Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Polycystic Ovary Syndrome 2Obesity 1

Interventions

Metformin 9Liraglutide 3Exercise 3semaglutide 2Tirzepatide 2Nutrition Assessment 2Docosahexaenoic Acids 2Diet 2sibutramine 1Ursodeoxycholic Acid 1Topiramate 1Solutions 1Resistance Training 1Propofol 1Progestins 1Nutrition Therapy 1Megestrol Acetate 1Medroxyprogesterone Acetate 1Magnetic Resonance Spectroscopy 1Injections 1Hysteroscopy 1Exenatide 1Estrogen Replacement Therapy 1Doxorubicin 1Cyproterone 1Cyclophosphamide 1Caloric Restriction 1(2-(1R)-1-cyclopropyl)ethyl-6-isopropyl-phenol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Obesity × Caloric Restriction × Clear all
NCT05702905 2024-03-25

Semaglutide Improves Metabolic Abnormalities and Fertility in Obese Infertile Women With Polycystic Ovary Syndrome

Peking University First Hospital

Phase 4 Unknown
75 enrolled
Other

Obesity, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡